Clinical Practice
Effect of increased body mass index and anaesthetic duration on recovery of protective airway reflexes after sevoflurane vs desflurane

https://doi.org/10.1093/bja/aep374Get rights and content
Under an Elsevier user license
open archive

Background

Increased BMI may increase the body's capacity to store potent inhaled anaesthetics, more so with more soluble agents. Accordingly, we asked whether increased BMI and longer anaesthesia prolonged airway reflex recovery.

Methods

We measured time from anaesthetic discontinuation until first response to command (T1); from response to command until ability to swallow (T2); and from anaesthetic discontinuation to recovery of ability to swallow (T3) in 120 patients within three BMI ranges (18–24, 25–29, and ≥30 kg m−2). All received sevoflurane or desflurane, delivered via an LMA.

Results

T1 and T3 after sevoflurane exceeded T1 and T3 after desflurane: 6.6 (sd 4.2) vs 4.0 (1.9) min (P<0.001), and 14.1 (sd 8.3) vs 6.1 (2.0) min (P<0.0001). T3 correlated more strongly with BMI after sevoflurane (28 s per kg m−2, P=0.02) than desflurane (7 s per kg m−2, P=0.03). Regarding T2, patients receiving sevoflurane with BMI ≥30 kg m−2 were less often able to swallow 2 min after response to command than were those with BMI 18–24 or 25–29 kg m−2 (3/20 vs 10/20 or 9/20, P<0.05). Each sevoflurane MAC-hour delayed T3 by 4.5 min (268 s) (R=0.46, P<0.001) whereas each desflurane MAC-hour delayed T3 by 0.2 min (16 s) (R=0.10, P=0.44).

Conclusions

Prolonged sevoflurane administration and greater BMI delay airway reflex recovery. The contribution of BMI to this delay is more pronounced after sevoflurane than desflurane.

airway, reflexes
anaesthetics, desflurane
anaesthetics, sevoflurane
anaesthetics, volatile
pharmacokinetics, obesity
pharmacokinetics, uptake

Cited by (0)

Interim findings from this trial were presented as a poster at the 2008 European Society of Anaesthesia in Copenhagen, Denmark. European Journal of Anaesthesiology 2008; 25 (Suppl 44): 2AP2–7.

Declaration of interest. R.E.M. has received research support in the past from Baxter Healthcare for other studies, but did not receive support for this study. She has also received honoraria for speaking from Baxter Healthcare. Baxter manufactures sevoflurane and desflurane. R.E.M. is a member of the Speakers Bureau for Baxter Healthcare, manufacturer of sevoflurane and desflurane. In addition, Baxter Healthcare has provided research support to the University of California for some of R.E.M.'s investigator-initiated projects in the past.